Clinical trials
Pulmonary clinical trials
Below are recruiting pulmonary clinical trials, each written for real people, not researchers. We’re tracking 1,310 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07359599RecruitingPhase 4
IV iron for exercise and quality of life in pulmonary hypertension
This study tests whether intravenous (IV) iron can help people with pulmonary hypertension feel better, have more energy, and enjoy a better quality of life. You may qualify if you have a type of pulmonary hypertension and low iron levels.
AalstAges 18 years+ - NCT07357623RecruitingPhase 2
Surufatinib with or without chemo for lung neuroendocrine tumors
This trial tests whether adding chemotherapy to the drug surufatinib works better than surufatinib alone for people with a rare type of lung cancer called pulmonary neuroendocrine tumor. If you have this diagnosis and haven't had prior systemic treatment, you may be eligible.
Hefei, AnhuiAges 18–75 - NCT06010563Recruiting
Study of a new heart valve for severe pulmonary valve leakage
This study tests a new less-invasive heart valve (VenusP-Valve) for people whose own pulmonary valve is leaking severely. If you qualify, you could get the new valve without open-heart surgery.
Irvine, CaliforniaAges 12 years+ - NCT06850961Recruiting
Digital health app for COPD self-management
This study tests a digital health app to help you manage COPD symptoms on your own. It focuses on people who have trouble with mucus and want to use a smartphone for their care.
Bergen, NorwayAges 18–90 - NCT06852924Recruiting
Inhaled nitric oxide for HAPE treatment trial
This trial tests if inhaled nitric oxide helps people with high-altitude pulmonary edema (fluid in the lungs from high altitude). It may offer a new treatment option for those with mild to moderate symptoms.
Lhasa, TibetAges 18–65 - NCT06453421Recruiting
Breathing and exercise rehab for long-term breathing machine patients
This study tests a special breathing and exercise program for people who have been on a breathing machine for a long time through a tracheostomy. The program is designed to help them get stronger and breathe better.
FlorenceAges 18 years+ - NCT07349524RecruitingPhase 2
A study of an oral tablet for COPD
This study tests an oral tablet called RSS0343 for people with moderate to severe COPD. It aims to see if the tablet can improve lung function and reduce flare-ups when added to your current breathing treatments.
Guangzhou, GuangdongAges 40–80 - NCT07339800Recruiting
CT scan for lung infection caused by Mucorales fungus
This trial looks at CT scan results to see if they can help predict how someone with a serious lung infection caused by Mucorales fungus will do. It asks whether certain features on CT scans can give clues about recovery and future health.
StrasbourgAges 18 years+ - NCT07332117Recruiting
Studying body changes in IPF and PPF patients starting anti-fibrotic drugs
This study uses safe, painless scans (like muscle ultrasound and a body composition test) to track changes in muscle and fat in patients with IPF or PPF who are starting anti-fibrotic medication. The goal is to better understand how these treatments affect your body.
LondonAges 18 years+ - NCT06443580Recruiting
A mind-body program for pulmonary hypertension
This trial tests a program that helps you notice and manage body signals (like breathlessness) to improve how you feel day-to-day. It is designed for people with any type of pulmonary hypertension.
Glasgow, ClydebankAges 18 years+ - NCT07318597RecruitingPhase 2
A study of an experimental drug for pulmonary arterial hypertension
This trial tests a new medication called REGN13335 for people with pulmonary arterial hypertension (PAH). It aims to see if the drug can improve symptoms and function compared to standard care alone.
Aurora, ColoradoAges 18 years+ - NCT07320846Recruiting
Exercise and gene activity in rheumatoid arthritis
This trial tests whether exercise training can affect gene activity (lncRNA) in rheumatoid arthritis patients with lung involvement. It may show how exercise helps manage the disease.
Istanbul, TurkeyAges 18–75 - NCT07322133RecruitingPhase 4
Comparing two blood pressure medicines for newborns with lung hypertension
This trial compares two medicines (dopamine and norepinephrine) to see which works better for raising blood pressure in newborns who have both low blood pressure and high blood pressure in the lungs. Both medicines are given through a vein to help stabilize your baby's blood pressure.
Sacramento, CaliforniaAges Up to 4 weeks - NCT07311135Recruiting
Smartwatch Oxygen Accuracy in Pulmonary Hypertension
This study tests how well a smartwatch measures oxygen levels in people with pulmonary hypertension during a 6-minute walk. It could help find a simpler way to check oxygen at home.
GlasgowAges 18 years+ - NCT07312305Recruiting
Small airways test in idiopathic pulmonary fibrosis
This study measures how well the small airways in your lungs work if you have idiopathic pulmonary fibrosis (IPF). It aims to find better ways to assess the disease and could lead to improved care.
Milan, LombardyAges 18 years+ - NCT07315347Recruiting
Treating blood clots in the lung at home for cancer patients
This study tests whether people with active cancer and a new blood clot in the lung can be safely treated at home instead of in the hospital. If you have cancer and a blood clot that is not causing severe symptoms, you may be able to join this trial.
Colombes, FranceAges 18 years+ - NCT07313501Recruiting
Comparing PERC and YEARS for diagnosing pulmonary embolism
This study compares two ways of checking for a pulmonary embolism (a blood clot in the lung) in the emergency room. It looks at the PERC score and the YEARS algorithm to see if they can help doctors decide when to do a D-dimer test and chest imaging, potentially reducing unnecessary tests.
StrasbourgAges 18 years+ - NCT07309393Recruiting
Comparing two muscle relaxant reversal drugs after lung surgery
This trial tests two different medicines used to reverse muscle relaxation after lung surgery. It looks at which one helps you breathe better in the first hours after your procedure.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07306468Recruiting
Exercise and lung health in schizophrenia and bipolar disorder
This study looks at how schizophrenia or bipolar disorder affects your ability to exercise, your lung function, and overall quality of life. It compares people with these conditions to healthy volunteers.
Çankırı, ÇankırıAges 18–65 - NCT07304856Recruiting
Studying lung involvement in women with LAM or TSC
This trial examines tiny particles called extracellular vesicles from your blood to see if they can help doctors understand lung problems in women with lymphangioleiomyomatosis (LAM) or tuberous sclerosis complex (TSC). It may help find new ways to track the disease without invasive tests.
Milan, MilanoAges 18–80 - NCT07303699RecruitingPhase 2
Atorvastatin with TB meds: a drug study for TB patients
This study tests if adding the cholesterol drug atorvastatin to standard TB treatment can help clear the infection faster. It looks at how the body processes the drugs and how well they work together.
Zaria, Kaduna StateAges 12 years+ - NCT07295938RecruitingPhase 2
Traditional Chinese medicine as an add-on treatment for mycobacterium abscessus in the lungs
This study tests if adding traditional Chinese medicine to standard treatment helps people with a lung infection called Mycobacterium abscessus. It may improve recovery and reduce side effects.
BeijingAges 18–75 - NCT07288554RecruitingPhase 1
Study of BBT002 for healthy people and COPD patients
This trial tests an experimental drug called BBT002 in healthy volunteers and people with chronic obstructive pulmonary disease (COPD), a lung condition that makes breathing hard. It aims to see if the drug is safe and how the body processes it.
Hefei, AnhuiAges 18–75 - NCT07292714RecruitingPhase 2
Testing 9MW1911 for people with moderate to severe COPD
This trial tests a new medication called 9MW1911 to see if it can help people with moderate to severe COPD who have had recent flare-ups. It is for current or former smokers ages 40 to 75 who are already on standard COPD treatments.
Chizhou, AnhuiAges 40–75
Hear when a new Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary?
- Yes. Clin2 currently lists 1,310 recruiting pulmonary studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.